Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.
A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.
As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...
The University of Nebraska said it was waiting for more information about what a pause in activities at the National ...
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...
With the CTSA funding, UB will build on its strong success improving health outcomes and addressing health disparities in WNY.
UofL was recently awarded its largest clinical research investment in the institution's history with $11.7 million from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback